Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $47
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Nathan Treybeck has maintained an Overweight rating on PROCEPT BioRobotics (NASDAQ:PRCT) and increased the price target from $44 to $47.
January 09, 2024 | 1:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Nathan Treybeck maintains an Overweight rating on PROCEPT BioRobotics and raises the price target from $44 to $47.
The increase in price target by a reputable analyst like Nathan Treybeck suggests a positive outlook on the company's stock, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100